| Literature DB >> 11267623 |
F A Oliveira1, R N de Almeida, M F Sousa, J M Barbosa-Filho, S A Diniz, I A de Medeiros.
Abstract
A new tryptamine analogue, N-salicyloyltryptamine (STP), a potential central nervous system (CNS) depressant, was tested in the pentylenetetrazol (PTZ) and maximal electroshock (MES) models of epilepsy in mice. When administered concurrently, STP (100 mg/kg ip) significantly reduced the number of animals that exhibited PTZ-induced seizures and eliminated the extensor reflex of maximal electric-induced seizures test in 50% of the experimental animals. In addition, it showed protection in the PTZ test by diminishing the death rate.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11267623 DOI: 10.1016/s0091-3057(00)00484-6
Source DB: PubMed Journal: Pharmacol Biochem Behav ISSN: 0091-3057 Impact factor: 3.533